Height, age at menarche, and risk of epithelial ovarian cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 8, 2005, Pages 2045-2048

  Jordan, Susan J ^a,b   Webb, Penelope M ^a   Green, Adèle C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE; SOMATOMEDIN C;

ADULT; AGING; ARTICLE; AUSTRALIA; BODY HEIGHT; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MUCINOUS BORDERLINE OVARIAN CANCER; OVARY CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; AGE FACTORS; AUSTRALIA; BODY HEIGHT; CHILD; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 23844466910     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0085     Document Type: Article

References (29)

1. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, et al. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-8.
2. Engeland A, Tretli S, Bjorge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003;95:1244-8.
3. Schouten L, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands Cohort Study on diet and cancer. Am J Epidemiol 2003;157:424-33.
4. Jonsson F, Wolk A, Pedersen NL, et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 2003;106:594-9.
5. Kuper H, DW C, Titus-Ernstoff L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status. Cancer Causes Control 2002;13:455-63.
6. Lukanova A, Toniolo P, Lundin E, et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 2002;99:603-8.
7. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in White women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-203.
8. Purdie D, Green A, Bain C, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of women's health study group. Int J Cancer 1995;62:678-84.
9. Hankinson S, Colditz G, Hunter D, et al. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 1995;76:284-90.
10. Titus-Ernstoff L, Perez K, Cramer D, et al. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 2001;84:714-21.
11. Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 2001;83:575-85.
12. Riman T, Dickman P, Nilsson S, et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 2002;156:363-73.
13. Risch H, Marrett L, Jain M, et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 1996;144:363-72.
14. Tung KH, Goodman MT, Wu AH, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003;158:629-38.
15. Purdie D, Webb PM, Siskind V, et al. The different etiologies of mucinous and non-mucinous epithelial ovarian cancers. Gynecol Oncol 2003;88:s145-8.
16. Australian National Audit Office. Integrity of the electoral role. In: Canberra (Australia): Australian National Audit Office; 2002. Available from: http://www.anao.gov.au/WebSite.nsf/Publications/4A256AE90015F69BCA256 B9E007B5F52, accessed December 17, 2004.
17. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003;27:985-93.
18. Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon (France): IARC Press; 2003.
19. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in White women. Collaborative ovarian cancer group. Am J Epidemiol 1992;136:1204-11.
20. Modugno F, Ness RB, Wheeler J. Reproductive risk factors for epithelial ovarian cancer according to histological type and invasiveness. Ann Epidemiol 2001;11:568-74.
21. Gunnell D, Okasha M, Smith GD, et al. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23:313-42.
22. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
23. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and metaregression analysis. Lancet 2004;363:1346-53.
24. Lukanova A, Lundin E, Toniolo P, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002;101:549-54.
25. Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem 1984;20:231-6.
26. Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983;57:82-6.
27. Clavel-Chapelon F. Evolution of age at menarche and at onset of regular cycling in a large cohort of French women. Hum Reprod 2002;17:228-32.
28. Rodriguez GC, Walmer DK, Cline M, et al. Effect of progestin on the ovariar epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 1998;5:271-6.
29. Edmondson RJ, Monaghan JM, Davies BR. The human ovarian surface epithelium is an androgen responsive tissue. Br J Cancer 2002;86:879-85.